Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

November 2013

New Medical Policy on Bulking Agents for Fecal Incontinence 


Effective December 1, 2013, Harvard Pilgrim has established a medical policy on the use of injectable bulking agents to treat fecal incontinence in adults. Solesta is currently the only injectable fecal bulking agent available on the market. Because current medical literature does not support the long-term effectiveness and medical necessity of fecal bulking agents, Harvard Pilgrim will continue to deny coverage. This policy is consistent with the practices of other health plans in the region, as well. For more information, please review Harvard Pilgrim's Bulking Agents for Treatment of Fecal Incontinence Medical Policy.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Sign Up for Electronic Funds Transfers

Registration Begins for Medicare Advantage StrideSM (HMO) Plans

CLINICIAN CORNER

Zostavax Available from Specialty Pharmacy

Knee Arthroscopy Medical Review Criteria Update

New Medical Policy on Bulking Agents for Fecal Incontinence

Do You Really Need to Prescribe an Antibiotic?

HEDIS Spotlight: Controlling High Blood Pressure

Resource Kit on LGBT Health Issues

OFFICE ASSISTANT

Your Feedback is Important to Us

Payment Policy Update: Viral Hepatitis Serology

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator